DELBIO, Inc

Ｍicro CT
  a. One touch /Auto-setting
  b. 2 sec. / Fast-scan
  c. 9 µm / High- resolution

2. Mesh Nebulizer
  a. Low residual medicine
  b. Patented mediation chamber design
  c. High nebulization rate

3. Veterinary X ray stationary
  a. One touch setting
  b. Two position
  c. Three type HV generator

4. Blood Glucose Monitoring System
  a. DFTTM Technology
  b. Fast Testing
  c. Easy to Use

5. Oximeter
  a. High Performance / High Sensitivity
  b. Non-Invasive Technology
  c. Compact Size Easy to Carry

6. Medical Ultrasound Imaging System
  a. Portable System
  b. High Imaging Quality
  c. Smart Design

 

Deloitte

DHYANA BIO TECHNOLOGY CORP.

Dhyana.KTE

Diamond BioFund Inc.

Diamond BioFund Inc. is the largest fund dedicated to biotechnology innovation and also the first evergreen fund in Taiwan, managing assets worth over 260 million USD. We invited 5 companies from new drugs development, medical devices, diagnostics, and innovative healthcare services in healthcare areas, including 3D Global Biotech, StemCyte, SINEW PHARMA, Iridium Medical Technology and CHO PHARMA to join Taiwan Healthcare+ EXPO. In addition, three major members of Microbio Group, Microbio Co., Ltd. with two successful drug approvals by the Taiwan Food and Drug Administration (TFDA), Oneness Biotech Co., Ltd. and FOUNTAIN BIOPHARMA will also participate in this event.

Ditmanson Medical Foundation Chia-yi Christian Hospital

1. Recent Advances in Strabismus Surgery
2. The milestone of spine surgery: percutaneous endoscopic decompression
3. Perfect New Methods for Management of Urolithiasis: Retrograde Intrarenal Surgery plus Tubeless Percutaneous Renal Surgery
4. Achieving an outstanding hospital in four cancer screenings
5. Integrating community service and home based medical care for the older people – a novel developing model

DNArails CO. Ltd.

DNArails is the first company in Taiwan to focus on genomics analysis and variants interpretation software development. Our self-developed product, the GENISYS (Genetic Information System), is the world-leading genome data interpretation system, an end-to-end solution provided to the clinical laboratory for genetic testing in cancer, reproductive medicine, hereditary diseases and other areas. To break down the wall between big data and clinically useful information, all APPs provide automated analysis process and visualize interpretation results which can make you identify the clinical significant easier than before. The uploaded samples will be annotated with more than 50 genome databases and backup to high-security cloud storage server that you can monitor all testing process record at one place. The pipeline and default parameters are mainly following up the FDA and ACMG recommendation guideline to ensure the analysis correctness. We also apply artificial intelligence algorithm into our system to deliver reliable clinical prediction for unknown single nucleotide variants.

DYSK Labs Co. Ltd.

Cloud-based whole slide histopathology image database, browsing interface, and deep-learning based image analysis system